In vitro activity of the aryl-fluoroquinolones A-56619 and A-56620 and evaluation of disk susceptibility tests
- 1 February 1986
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 5 (1) , 18-22
- https://doi.org/10.1007/bf02013455
Abstract
The activity of two new quinolones, A-56619 and A-56620, was compared in vitro to that of norfloxacin and ciprofloxacin against 6,699 bacterial isolates in four separate clinical laboratories. The overall percentage of strains susceptible to designated concentrations were as follows: 99.1% for norfloxacin (MIC⩽4.0 μ g/ml), 96.1% for ciprofloxacin (MIC⩽1.0 μ g/ml), 96.8% for A-56620 (MIC ⩽ 2.0 μ g/ml) and 96.1% for A-56619 (MIC⩽ 4.0 μ g/ml). For disk diffusion susceptibility tests 10 μ g A-56619 disks are tentatively recommended with interpretive standards of ⩾ 18mm for susceptibility and ⩽ 13mm for resistance; 5 μ g A-56620 disks may be used with tentative standards of ⩾ 19mm for susceptibility and ⩽ 14mm for resistance.This publication has 1 reference indexed in Scilit:
- In vitro activities of the quinolone antimicrobial agents A-56619 and A-56620Antimicrobial Agents and Chemotherapy, 1985